Trichomonicidal and parasite membrane damaging activity of bidesmosic saponins from Manilkara rufula

The infection caused by Trichomonas vaginalis is the most common but overlooked non-viral sexually transmitted disease worldwide. Treatment relies on one class of drugs, the 5-nitroimidazoles, but resistance is widespread. New drugs are urgently needed. We reported the effect of crude and purified saponin fractions of Manilkara rufula against Trichomonas vaginalis. The compound responsible for antitrichomonal activity was isolated and identified as an uncommon bidesmosic saponin, Mi-saponin C. This saponin eliminated parasite viability without toxicity against the human vaginal epithelial line (HMVII). In addition, the isolated saponin fraction improved the metronidazole effect against a metronidazole-resistant isolate and dramatically reduced the cytoadherence of T. vaginalis to human cells. Investigation of the mechanism of death showed that the saponin fraction induced the parasite death due to profound membrane damage, inducing a disturbance of intracellular content without nuclear damage. To the best of our knowledge, this is the first report of antitrichomonal activity in the bidesmosic saponins of Manilkara rufula.

[1]  Odelta dos Santos,et al.  Trichomonas vaginalis clinical isolates: cytoadherence and adherence to polystyrene, intrauterine device, and vaginal ring , 2017, Parasitology Research.

[2]  T. Tasca,et al.  Trichomonas vaginalis: cytochemical localization of a NTPDase1 and an ecto-5′-nucleotidase and effects of adenine nucleotides on cellular viability , 2004, Parasitology Research.

[3]  P. Chaimbault,et al.  Pentacyclic triterpenes from Manilkara bidentata resin. Isolation, identification and biological properties. , 2013, Fitoterapia.

[4]  R. Faure,et al.  Isolation and biological study of a triterpenoid saponin, mimengoside A, from the leaves of Buddleja madagascariensis. , 1996, Planta Medica.

[5]  R. Vancini,et al.  Cell death in trichomonads: new insights , 2006, Histochemistry and Cell Biology.

[6]  N. C. Saxena,et al.  Phase II clinical trial with Praneem polyherbal tablets for assessment of their efficacy in symptomatic women with abnormal vaginal discharge (an ICMR task force study). , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  R. Faure,et al.  Antifungal and antiprotozoal activities of saponins from Hedera colchica. , 2000, Die Pharmazie.

[8]  R. B. Giordani,et al.  Lycorine induces cell death in the amitochondriate parasite, Trichomonas vaginalis, via an alternative non-apoptotic death pathway. , 2011, Phytochemistry.

[9]  A. Harvey,et al.  The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.

[10]  Dejian Huang,et al.  Profiles and α-amylase inhibition activity of proanthocyanidins in unripe Manilkara zapota (chiku). , 2012, Journal of agricultural and food chemistry.

[11]  N. Lopes,et al.  Caatinga plants: Natural and semi-synthetic compounds potentially active against Trichomonas vaginalis. , 2016, Bioorganic & medicinal chemistry letters.

[12]  E. Haggag,et al.  A novel saponin from Manilkara hexandra seeds and anti-inflammatory activity , 2014, Medicinal Chemistry Research.

[13]  H. Kuang,et al.  A strategy for characterization of triterpene saponins in Caulophyllum robustum hairy roots by liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry. , 2014, Journal of pharmaceutical and biomedical analysis.

[14]  R. Kirkcaldy,et al.  Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010 , 2012, Emerging infectious diseases.

[15]  G. Garber,et al.  Clinical and Microbiological Aspects ofTrichomonas vaginalis , 1998, Clinical Microbiology Reviews.

[16]  Z. Wiesman,et al.  Metabolite profiling of saponins in Balanitesaegyptiaca plant tissues using LC (RI)-ESI/MS and MALDI-TOF/MS , 2008, Metabolomics.

[17]  P. Paiva,et al.  Screening of Caatinga plants as sources of lectins and trypsin inhibitors , 2014, Natural product research.

[18]  L. S. Diamond.  The establishment of various trichomonads of animals and man in axenic cultures. , 1957, The Journal of parasitology.

[19]  C. Lavaud,et al.  Saponins from the seeds of Mimusops laurifolia. , 2006, Phytochemistry.

[20]  D. Newman,et al.  Natural Products as Sources of New Drugs from 1981 to 2014. , 2016, Journal of natural products.

[21]  R. Fichorova.  Impact of T. vaginalis infection on innate immune responses and reproductive outcome. , 2009, Journal of reproductive immunology.

[22]  Margaret J. Basile,et al.  Bioactive novel polyphenols from the fruit of Manilkara zapota (Sapodilla). , 2003, Journal of natural products.

[23]  G. Gosmann,et al.  Anti-Trichomonas vaginalis activity from triterpenoid derivatives , 2014, Parasitology Research.

[24]  J. Ryu,et al.  Trichomonas vaginalis: reactive oxygen species mediates caspase-3 dependent apoptosis of human neutrophils. , 2008, Experimental parasitology.

[25]  C. Franco,et al.  Discovery of Novel Saponins from the Viscera of the Sea Cucumber Holothuria lessoni , 2014, Marine drugs.

[26]  M. Simmonds,et al.  Metabolomic analysis of saponins in crude extracts of Quillaja saponaria by liquid chromatography/mass spectrometry for product authentication. , 2004, Rapid communications in mass spectrometry : RCM.

[27]  R. B. Giordani,et al.  Natural and synthetic compound anti-Trichomonas vaginalis: an update review , 2015, Parasitology Research.

[28]  D. Beach,et al.  Cytopathogenic Effect of Trichomonas vaginalis on Human Vaginal Epithelial Cells Cultured In Vitro , 2000, Infection and Immunity.

[29]  G. Gosmann,et al.  Anti-Trichomonas vaginalis activity of saponins from Quillaja, Passiflora, and Ilex species , 2012, Parasitology Research.

[30]  J. Schwebke,et al.  The clinical spectrum of Trichomonas vaginalis infection and challenges to management , 2013, Sexually Transmitted Infections.

[31]  H. Wagner,et al.  A review of the biological and pharmacological activities of saponins. , 1996, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[32]  N. Lopes,et al.  The Caatinga endemic Manilkara rufula possesses remarkable activity against Trichomonas vaginalis and Tritrichomonas foetus. , 2017, Experimental parasitology.

[33]  J. Martinez-de-Oliveira,et al.  New strategies for local treatment of vaginal infections. , 2015, Advanced drug delivery reviews.

[34]  V. Kaul,et al.  Multistage and tandem mass spectrometry of glycosylated triterpenoid saponins isolated from Bacopa monnieri: comparison of the information content provided by different techniques. , 2007, Analytical chemistry.

[35]  I. Barasoain,et al.  Centrosome and spindle pole microtubules are main targets of a fluorescent taxoid inducing cell death. , 2001, Cell motility and the cytoskeleton.

[36]  J. Lamas,et al.  Hydrogenosome Metabolism Is the Key Target for Antiparasitic Activity of Resveratrol against Trichomonas vaginalis , 2013, Antimicrobial Agents and Chemotherapy.

[37]  A. P. Frasson,et al.  Involvement of purinergic signaling on nitric oxide production by neutrophils stimulated with Trichomonas vaginalis , 2011, Purinergic Signalling.

[38]  S. Bak,et al.  Molecular activities, biosynthesis and evolution of triterpenoid saponins. , 2011, Phytochemistry.

[39]  M. Singh,et al.  Anti-Trichomonas activity of Sapindus saponins, a candidate for development as microbicidal contraceptive. , 2008, The Journal of antimicrobial chemotherapy.

[40]  A. Pichette,et al.  Haemolytic activity, cytotoxicity and membrane cell permeabilization of semi-synthetic and natural lupane- and oleanane-type saponins. , 2009, Bioorganic & medicinal chemistry.